NGS — Nutritional Growth Solutions Income Statement
0.000.00%
Last trade - 00:00
- AU$1.49m
- AU$1.78m
- $2.98m
- 15
- 55
- 15
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.18 | 1.87 | 3.04 | 2.95 | 2.98 |
Cost of Revenue | |||||
Gross Profit | 0.546 | 0.92 | 1.36 | 1.44 | 0.842 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.3 | 4.12 | 7.77 | 7.29 | 6.05 |
Operating Profit | -2.11 | -2.25 | -4.73 | -4.34 | -3.07 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.03 | -4.36 | -4.78 | -4.25 | -2.89 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.03 | -4.36 | -4.78 | -4.25 | -2.89 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.03 | -4.36 | -4.78 | -4.25 | -2.89 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.03 | -4.36 | -4.78 | -4.25 | -2.89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.021 | -0.046 | -0.05 | -0.03 | -0.015 |
Dividends per Share |